The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan

Sruamsiri, Rosarin; Kaneko, Yuko; Mahlich, Jörg

doi:10.1186/s41927-017-0003-6

Cited by 36 publications

(11 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our sample, 35% of patients were identified as suffering from either mild (24%) or severe (11%) depression. It has also been shown that depression in Japan often remains undiagnosed [50,51]. We found that while 89% of the patients in our Japanese sample of RA patients reported being satisfied with their current treatment, only 72% of those patients with severe depression were satisfied.…”

Section: Discussionmentioning

confidence: 47%

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment

2019

Self Cite

View full text Add to dashboard Cite

Introduction We have developed a new framework to assess shared decision-making (SDM) as a tool to improve patient satisfaction. This framework is based on a “preference fit” index that relates SDM to patient treatment preferences and patient satisfaction in a sample of rheumatoid arthritis (RA) patients in Japan. Methods We surveyed 500 RA patients in Japan and explored the interactions between the treatment preference fit index, SDM, and overall patient satisfaction. Results Our new preference fit index reveals significant impact on patient satisfaction: the better the fit between SDM and patient preferences, the higher the patient satisfaction with the current treatment. Patients treated with biologic agents were more satisfied. Patients suffering from depression or migraines scored significantly lower both on our preference fit measure and for overall patient satisfaction. Conclusion The association between depression and a low treatment preference fit suggests that depression may pose challenges to SDM and that doctors in Japan are less attuned to the SDM preferences of depressed patients. Funding Janssen Pharmaceutical KK.

show abstract

Section: Discussionmentioning

confidence: 47%

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment

2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…The PHQ-9 is a versatile self-reporting tool used for measurement of depression severity, diagnosis, as well as screening for the disease [19]. The study also found that among the RA population, younger patients, those affected by greater functional impairment, or patients on pain relief medications not biologic agents were more likely to experience depression [20]. Data from the Japanese IORRA registry also indicate that up to 41% of the RA patients were identified as depressed patients using a two-question screening tool [21], while a more recent study reported prevalence rates between 6.8 and 23.5% in depending on the tool that was used to determine depression [22].…”

Section: Discussionmentioning

confidence: 55%

Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data

Guelfucci

Kaneko

Mahlich³

et al. 2018

Rheumatol Ther

Self Cite

View full text Add to dashboard Cite

“…Asian people are known to be reluctant to seek psychiatric treatment due to the stigma of mental illness 27 – 29 . In Japan, only 5% of the Japanese patients with rheumatoid arthritis had been diagnosed with depression, while 35% of the same population had PHQ-9 scores indicative of depression 30 . Increasing annual prevalence from 2002 to 2013 approaching the level of high-income western countries and decreased population with unmedicated depression (Fig.…”

Section: Discussionmentioning

confidence: 99%

Increased prevalence of depression in South Korea from 2002 to 2013

Kim

Shin

2020

Sci Rep

102

View full text Add to dashboard Cite

South Korea has one of the highest suicide rates among countries. However, the prevalence of depression in South Korea has been reported to be much lower than in other countries. The current study aims to estimate the prevalence of major depressive disorder using a large representative sample of the South Korean population. The prevalence of depression in a sampled population of one million individuals increased from 2.8% in 2002 to 5.3% in 2013; it was found to increase with the age of the population, and was higher in females than in males for most age groups. A Cox’s proportional hazard model showed that suicide risk was significantly higher in people with depression (hazard ratio [HR] 3.79, 95% CI 3.14–4.58) than those without depression. It was also significantly higher in older people (HR 1.52, 95% CI 1.36–1.70) than in younger people, and in males (HR 2.45, 95% CI 2.02–2.96) than in females. Furthermore, higher income groups were at lower suicide risk as compared to lower income groups (HR 0.88, 95% CI 0.80–0.95). This study using the large representative sample data provided evidence that increased prevalence of depression contributed to the increased risk of suicide in South Korea during the recent decade.

show abstract

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan

Cited by 36 publications

References 39 publications

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment

Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data

Increased prevalence of depression in South Korea from 2002 to 2013

Contact Info

Product

Resources

About